OTC Watch

All stocks / STEK

Stemtech Corp STEK

Stemtech (STEK): shares outstanding up 1192% in a year, a late 10-Q/A notice in May 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.

DilutionEstimated floatLate filing OTCIDFlorida, USA
Live quote on OTC Markets

Market listing

Full name
STEMTECH CORP
Market tier
OTC Pink Current
Trading status
Active
Last trade
Nov 16
Source: Stockwatch, 2026-11-17

News headlines

Physician Research Points to a New Frontier for Stemtech Corporation: Nutritional Activation of the Body's Endogenous Regenerative System
2026-10-08 08:30 · News Release
Physician Cites Stemtech as "Cornerstone" Behind His Focus on STEM Cell Medicine
2026-09-22 08:30 · News Release
Stemtech Corporation Appoints Alejandro Carrillio President, Latin Markets
2026-08-20 08:30 · News Release
Stemtech Corporation Declares July 2026 "Cellular Health Awareness Month"
2026-07-01 08:30 · News Release
Stemtech Corporation Issues 2025 Year-In-Review Letter Highlighting Corporate Strength, Global Expansion and Accelerating Market Opportunities
2026-06-23 08:31 · News Release
Stemtech Secures Inventory Funding
2026-04-07 08:30 · News Release
Stemtech Revolution 2026: A Bold New Era In Global Wellness
2026-03-18 08:30 · News Release
Stemtech Corporation Launches New Market Channel Biosciences Ecommerce
2026-02-26 08:30 · News Release
Stemtech Corporation Welcomes Dr. Zahooruddin To Life Sciences Advisory Board
2026-02-03 08:30 · News Release
Stemtech Corporation Appoints Dr. Lizette Leos, MD To Chief Scientific Officer (CSO)
2026-01-06 08:30 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Revenue
$2,876,380
Net loss
($4,046,705)
What it means

It spends more than it earns

Under strain

Customers paid it $2.9 million in the year. It lost $4 million. For every $1 that came in, about $2.41 went out.

The report says
Cash and cash equivalents
$238,245
Net cash used in operating activities
($483,583)
What it means

The cash could run out soon

Under strain

It had $238,245 in the bank and used about $40,299 a month. At that pace the money lasts about 6 months unless it borrows or sells more shares.

The report says
Total assets
$3,149,614
Total liabilities
$10,587,013
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $3.1 million. Its debts and unpaid bills add up to $10.6 million. That is about $3.36 owed for every $1 owned.

What this adds up to

3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Dilution2026-11-13

Shares outstanding rose from 231,975,027 (2025-11-19) to 2,997,032,856 (2026-11-13), up 1192%.

Rule: Shares outstanding up 20% or more in 12 months. Source record

Estimated float2026-11-13

Estimated float about 2,997,032,856 shares as of 2026-11-13: 2,997,032,856 outstanding minus 0 held by 0 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Late filing2026-05-14

Filed NT 10-Q/A on 2026-05-14: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Late filing2026-05-14

Filed NT 10-Q on 2026-05-14: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Late filing2026-03-31

Filed NT 10-K on 2026-03-31: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Shares outstanding

Source: SEC filings
2025-12-31
426.0M
2026-03-31
1.65B
2026-05-26
2.07B
2026-06-22
2.37B
2026-06-30
2.74B
2026-08-13
3.00B
2026-09-30
3.00B
2026-11-13
3.00B

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-13 10-QFORM 10-Q FOR SEP 2026
2026-08-14 10-QFORM 10-Q FOR JUN 2026
2026-06-22 10-QQUARTERLY REPORT
2026-05-29 10-KFORM 10-K FOR DEC 2025
2026-05-14 NT 10-QNOTICE OF LATE FILING
2026-05-14 NT 10-Q/AAMENDMENT NO 1
2026-03-31 NT 10-KEXTENSION FOR DECEMBER 2025 10-K
2025-11-19 10-QFORM 10-Q FOR SEP 2025

Common questions about STEK

Does STEK file reports with the SEC?

Yes. Stemtech files with the SEC under company number 0001511820. The most recent filing we hold is a 10-Q dated 2026-11-13.

Source record

How many STEK shares are outstanding?

2,997,032,856 shares as of 2026-11-13, as reported to the SEC. That is up 1192% from 231,975,027 on 2025-11-19.

Source record

Has STEK filed reports late?

Yes. In the last 12 months it filed 3 late-filing notices, most recently a NT 10-Q/A on 2026-05-14. A notice means a report was not ready on time; check whether the report followed.

Source record

Is Stemtech making money?

Customers paid it $2.9 million in the year. It lost $4 million. For every $1 that came in, about $2.41 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record